Nymox Pharmaceutical Corporation news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

NYMX 0.990 -0.028 (-2.74%)
price chart
Is Nymox a Fluke or Is It Back?
Nymox Pharmaceutical Corp. (NASDAQ: NYMX) has been around for a long time, but within the past five years the stock has literally fallen off a cliff.
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) To Take Up Phase 3 BPH ...  USMarketsDaily (blog)
Healthcare Most Volatile : Nymox Pharmaceutical Corporation (NASDAQ:NYMX ...  eMarketsDaily
Class Action Lawsuit Filed Against Nymox Pharmaceutical Corporation and Paul ...
PHILADELPHIA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Law Offices Bernard M. Gross, P.C. filed a class action lawsuit in the United States District Court, District of New Jersey, 14-cv-07331, on behalf of purchasers of NYMOX common stock between January ...
Related articles »  
Nymox Pharma (NYMX) Reports No Top-Line Statistical Significance in NX-1207 ...
Nymox Pharmaceutical Corporation (Nasdaq: NYMX) announced today that the Company is undertaking further analyses of its pivotal U.S.
Nymox Pharmaceutical Corporation: Nymox Reports 2014 Financial Results  The Wall Street Transcript
Here's Why Nymox Nosedived Yesterday
Nymox is a biopharmaceutical that focuses on the development of novel therapeutics for the aging population. The company already has two products in the market - both being at-home tests. The first, called NicAlert, is used to test a person's smoking ...
Nymox Pharma (NYMX) Phase 3 Studies of NX-1207 Fail to Meet Primary ...  StreetInsider.com (subscription)
Nymox NX-1207 BPH Pivotal Phase 3 U.S. Studies NX02-0017 and NX02-0018 ...  GlobeNewswire (press release)
Related articles »  
Update: Short Interest of Nymox Pharmaceutical Corporation Increases by 18.8%
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has witnessed a rise of 18.8% or 158,210 shares in its short figure. The short interest augmentation took it from 841,737 on March 13,2015 to 999,947 on March 31,2015 .
Today's Pre-Market Information: Nymox Pharmaceutical Corporation (NYMX ...  WallStreet Scope
Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation ...
26, 2014 /PRNewswire/ -- Cohen, Placitella & Roth, PC is investigating potential claims on behalf of investors who purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") NYMX, -4.16% during the period from January 31, 2011 through ...
Related articles »  
Is Nymox Pharmaceutical Corp. (NASDAQ:NYMX)Back in Action?
One company that has been in the market for a pretty long time now thus making us accustomed to it is Nymox Pharmaceutical Corp. (NASDAQ:NYMX). However, in the last five years, Nymox Pharmaceutical Corp. (NASDAQ:NYMX)'s stock seems to have ...
Rosen Law Firm Reminds Nymox Pharmaceutical Corporation Investors of ...
NEW YORK, Jan. 12, 2015 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds purchasers of Nymox Pharmaceutical Corporation common stock (Nasdaq:NYMX) during the period from January 31, 2011 through November 2, 2014, of the important January ...
Robbins Arroyo LLP: Nymox Pharmaceutical Corporation (NYMX) Misled ...
SAN DIEGO and QUEBEC, Canada, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Nymox Pharmaceutical Corporation (Nasdaq:NYMX) has filed a federal securities fraud class action ...
Related articles »  
Fri Pre-Market Information: MAM Software Group, Inc. (MAMS), Nymox ...
Nymox Pharmaceutical Corporation (NYMX) of the Diagnostic Substances sector closed out the day Thursday at $1.02, a loss of -0.20% with a return on investment of 120.50% trading at a volume of 292,331 shares.